Effects of transplanted bone-marrow-derived mesenchymal stem cells in animal models of acute hepatitis

Cell and Tissue Research

Volumn 351, Issue 3, 2013, Pages 477-486

  Zhu, Xishan ^a   He, Baoxin ^a   Zhou, Xinna ^a   Ren, Jun ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

Cellular therapy; Differentiation; Hepatitis; Immune regulation; Immunoregulation; Mesenchymal stem cells; Mouse (C57bl 6); Natural killer Tcells

Indexed keywords

ACUTE HEPATITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BONE MARROW; BONE MARROW DERIVED MESENCHYMAL STEM CELL; CELL ACTIVITY; CELL FUNCTION; CELL ISOLATION; CELL MIGRATION; CONTROLLED STUDY; DONOR SELECTION; DOSE TIME EFFECT RELATION; FEMALE; GRAFT RECIPIENT; IMMUNOREGULATION; LIVER; LIVER CELL; LIVER INJURY; MESENCHYMAL STEM CELL; MESENCHYMAL STEM CELL TRANSPLANTATION; MOUSE; NATURAL KILLER T CELL; NONHUMAN; PRIORITY JOURNAL; THERAPY EFFECT; ACUTE DISEASE; ANIMAL; BONE MARROW CELL; C57BL MOUSE; CELL MOTION; CELL PROLIFERATION; CELL PROTECTION; CULTURE MEDIUM; CYTOLOGY; DISEASE MODEL; DRUG EFFECT; HEPATITIS; HUMAN; INFLAMMATION; MESENCHYMAL STROMA CELL; METABOLISM; PATHOLOGY;

ANIMALIA;

AUTACOID; CONCANAVALIN A; CYTOKINE; HYDROGEN PEROXIDE;

ACUTE DISEASE; ANIMALS; APOPTOSIS; BONE MARROW CELLS; CELL MOVEMENT; CELL PROLIFERATION; CONCANAVALIN A; CULTURE MEDIA, CONDITIONED; CYTOKINES; CYTOPROTECTION; DISEASE MODELS, ANIMAL; FEMALE; HEPATITIS; HUMANS; HYDROGEN PEROXIDE; INFLAMMATION; INFLAMMATION MEDIATORS; LIVER; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMAL CELLS; MICE; MICE, INBRED C57BL; NATURAL KILLER T-CELLS;

MLCS; MLOWN;

EID: 84881233763     PISSN: 0302766X     EISSN: 14320878     Source Type: Journal    
DOI: 10.1007/s00441-012-1524-3     Document Type: Article

References (34)

1. Anjos-Afonso F, Siapati EK, Bonnet D (2004) In vivo contribution of murine mesenchymal stem cells into multiple cell-types under minimal damage conditions. J Cell Sci 117:5655-5664
2. Arshad MI, Rauch M, L'helgoualc'h A, Julia V, Leite-de-Moraes MC, Lucas-Clerc C, Piquet-Pellorce C, Samson M (2011) NKT cells are required to induce high IL-33 expression in hepatocytes during ConA-induced acute hepatitis. Eur J Immunol 41:2341-2348
3. Bartholomew A, Sturgeon C, Siatskas M, Ferrer K, McIntosh K, Patil S, HardyW, Devine S, Ucker D, Deans R, Moseley A, Hoffman R (2002) Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo. Exp Hematol 30:42-48
4. Cao Y, Sun Z, Liao L, Meng Y, Han Q, Zhao RC (2005) Human adipose tissue-derived stem cells differentiate into endothelial cells in vitro and improve postnatal neovascularization in vivo. Biochem Biophys Res Commun 332:370-379
5. Chen F, Zhu HH, Zhou LF, Li J, Zhao LY, Wu SS, Wang J, Liu W, Chen Z (2010) Genes related to the very early stage of ConAinduced fulminant hepatitis: a gene-chip-based study in a mouse model. BMC Genomics 11:240
6. Choi YS, Jeong JA, Lim DS (2012) Mesenchymal stem cell-mediated immature dendritic cells induce regulatory T cell-based immunosuppressive effect. Immunol Invest 41:214-229
7. Deng W, Han Q, Liao L, Li C, Ge W, Zhao Z, You S, Deng H, Murad F, Zhao RC (2005) Engrafted bone marrow-derived flk-(1+) mesenchymal stem cells regenerate skin tissue. Tissue Eng 11:110-119
8. De Ugarte DA, Alfonso Z, Zuk PA, Elbarbary A, Zhu M, Ashjian P, Benhaim P, Hedrick MH, Fraser JK (2003) Differential expression of stem cell mobilization-associated molecules on multi-lineage cells from adipose tissue and bone marrow. Immunol Lett 89:267-270
9. Djouad F, Plence P, Bony C, Tropel P, Apparailly F, Sany J, Noel D, Jorgensen C (2003) Immunosuppressive effect of mesenchymal stem cells favors tumor growth in allogeneic animals. Blood 102:3837-3844
10. Duffield JS, Park KM, Hsiao LL, Kelley VR, Scadden DT, Ichimura T, Bonventre JV (2005) Restoration of tubular epithelial cells during repair of the postischemic kidney occurs independently of bone marrow-derived stem cells. J Clin Invest 115:1743-1755
11. Fang B, Shi M, Liao L, Yang S, Liu Y, Zhao RC (2004) Systemic infusion of FLK1(+) mesenchymal stem cells ameliorate carbon tetrachloride-induced liver fibrosis in mice. Transplantation 78:83-88
12. Francois S, Bensidhoum M, Mouiseddine M, Mazurier C, Allenet B, Semont A, Frick J, Sache A, Bouchet S, Thierry D, Gourmelon P, Gorin NC, Chapel A (2006) Local irradiation not only induces homing of human mesenchymal stem cells at exposed sites but promotes their widespread engraftment to multiple organs: a study of their quantitative distribution after irradiation damage. Stem Cells 24:1020-1029
13. Gnecchi M, He H, Liang OD, Melo LG, Morello F, Mu H, Noiseux N, Zhang L, Pratt RE, Ingwall JS, Dzau VJ (2005) Paracrine action accounts for marked protection of ischemic heart by Akt-modified mesenchymal stem cells. Nat Med 11:367-368
14. Herrera MB, Bussolati B, Bruno S, Fonsato V, Romanazzi GM, Camussi G (2004) Mesenchymal stem cells contribute to the renal repair of acute tubular epithelial injury. Int J Mol Med 14:1035-1041
15. Johann PD, Vaegler M, Gieseke F, Mang P, Armeanu-Ebinger S, Kluba T, Handgretinger R, Müller I (2010) Tumour stromal cells derived from paediatric malignancies display MSC-like properties and impair NK cell cytotoxicity. BMC Cancer 10:501
16. Krampera M, Glennie S, Dyson J, Scott D, Laylor R, Simpson E, Dazzi F (2003) Bone marrow mesenchymal stem cells inhibit the response of naive and memory antigen-specific T cells to their cognate peptide. Blood 101:3722-3729
17. Makohon NV, Pavlovych SI, Bryzhina TM, Aleksiuk LI, Sukhina VS, Hrushka NH, Aleksieieva IM (2008) Proliferation and death of liver mononuclear cells in immune lesions induced by concanavalin A and anti-liver antibodies in mice. Fiziol Zh 54:49-57
18. Mangi AA, Noiseux N, Kong D, He H, Rezvani M, Ingwall JS, Dzau VJ (2003) Mesenchymal stem cells modified with Akt prevent remodeling and restore performance of infarcted hearts. Nat Med 9:1195-1201
19. Mizuno H, Zuk PA, Zhu M, Lorenz HP, Benhaim P, Hedrick MH (1999) Myogenic differentiation by human processed lipoaspirate cells. Plast Reconstr Surg 109:199-209
20. Nakagawa H, Akita S, Fukui M, Fujii T, Akino K (2005) Human mesenchymal stem cells successfully improve skin-substitute wound healing. Br J Dermatol 153:29-36
21. Ortiz LA, Gambelli F, McBride C, Gaupp D, Baddoo M, Kaminski N, Phinney DG (2003) Mesenchymal stem cell engraftment in lung is enhanced in response to bleomycin exposure and ameliorates its fibrotic effects. Proc Natl Acad Sci USA 100:8407-8411
22. Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, Mosca JD, Moorman MA, Simonetti DW, Craig S, Marshak DR (1999) Multilineage potential of adult human mesenchymal stem cells. Science 284:143-147
23. Shi G, Zhang Z, Feng D, Xu Y, Lu Y, Wang J, Jiang J, Zhang Z, Li X, Ning G (2010) Selection of reference genes for quantitative realtime reverse transcription-polymerase chain reaction in concanavalin A-induced hepatitis model. Anal Biochem 401:81-90
24. Shi D, Liao L, Zhang B, Liu R, Dou X, Li J, Zhu X, Yu L, Chen D, Zhao RC (2011) Human adipose tissue-derived mesenchymal stem cells facilitate the immunosuppressive effect of cyclosporin A on T lymphocytes through Jagged-1-mediated inhibition of NF-κB signaling. Exp Hematol 39:214-224
25. Sordi V, Malosio ML, Marchesi F, Mercalli A, Melzi R, Giordano T, Belmonte N, Ferrari G, Leone BE, Bertuzzi F, Zerbini G, Allavena P, Bonifacio E, Piemonti L (2005) Bone marrow mesenchymal stem cells express a restricted set of functionally active chemokine receptors capable of promoting migration to pancreatic islets. Blood 106:419-427
26. Takeda K, Hayakawa Y, Van Kaer L, Matsuda H, Yagita H, Okumura K (2000) Critical contribution of liver natural killer T cells to a murine model of hepatitis. Proc Natl Acad Sci USA 97:5498-5503
27. Wada N, Bartold PM, Gronthos S (2011) Human foreskin fibroblasts exert immunomodulatory properties by a different mechanism to bone marrow stromal/stem cells. Stem Cells Dev 20:647-659
28. Weng JY, Du X, Geng SX, Peng YW, Wang Z, Lu ZS, Wu SJ, Luo CW, Guo R, Ling W, Deng CX, Liao PJ, Xiang AP (2011) Mesenchymal stem cell as salvage treatment for refractory chronic GVHD. Bone Marrow Transplant 45:1732-1740
29. Xishan Z, Guangyu A, Yuguang S, Hongmei Z (2011) The research on the immuno-modulatory defect of mesenchymal stem cell from chronic myeloid leukemia patients. J Exp Clin Cancer Res 30:47
30. Zappia E, Casazza S, Pedemonte E, Benvenuto F, Bonanni I, Gerdoni E, Giunti D, Ceravolo A, Cazzanti F, Frassoni F, Mancardi G, Uccelli A (2005) Mesenchymal stem cells ameliorate experimental autoimmune encephalomyelitis inducing T-cell anergy. Blood 106:1755-1761
31. Zhang W, Ge W, Li C, You S, Liao L, Han Q, Deng W, Zhao RC (2005) Effects of mesenchymal stem cells on differentiation, maturation, and function of human monocyte-derived dendritic cells. Stem Cells Dev 13):263-271
32. Zhang B, Liu R, Shi D, Liu X, Chen Y, Dou X, Zhu X, Lu C, Liang W, Liao L, Zenke M, Zhao RC (2009) Mesenchymal stem cells induce mature dendritic cells into a novel Jagged-2-dependent regulatory dendritic cell population. Blood 113:46-57
33. Zhao ZG, Xu W, Sun L, Li WM, Li QB, Zou P (2012) The characteristics and immunoregulatory functions of regulatory dendritic cells induced by mesenchymal stem cells derived from bone marrow of patient with chronic myeloid leukaemia. Eur J Cancer 48:1884-1895
34. Zhu X, Wang L, Zhang B, Li J, Dou X, Zhao RCJ (2011) TGFbeta1-induced PI3K/Akt/NF-kappaB/MMP9 signalling pathway is activated in Philadelphia chromosome-positive chronic myeloid leukaemia hemangioblasts. Biochem 149:405-414